MedTrace Logo

REpositionable Versus BallOOn-expandable Prosthesis for Trans-catheter Aortic Valve Implantation

NCT02668484 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2019-06-03

No results posted yet for this study

Summary

There are different aortic valve prosthesis used for treatment of aortic valve disease through catheter-based procedures. The current study aims to compare two different aortic valve prosthesis regarding their outcomes at 30-day and 2-year follow-up.

Conditions

  • Aortic Valve Disease

Interventions

DEVICE

repositionable valve prosthesis

repositionable valve prosthesis implanted via trans-femoral and trans-catheter route

DEVICE

balloon-expandable valve prosthesis

balloon-expandable valve prosthesis implanted via trans-femoral and trans-catheter route

Sponsors & Collaborators

  • LMU Klinikum

    lead OTHER

Principal Investigators

  • Julinda Mehilli, MD · Munich University Clinic, Ludwig-Maximilians University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-05-31
Completion
2019-05-31

Countries

  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02668484 on ClinicalTrials.gov